This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

China's Citic buys Singapore's Biosensors for $816 million

( November 4, 2015, 09:09 GMT | Official Statement) -- MLex Summary: Chinese private-equity firm Citic Private Equity Funds Management has agreed to buy the rest of Singapore-listed medical device maker Biosensors International for S$1.14 billion ($815.8 million). Citic already owns 19.57 percent of Biosensors, and is paying S$0.84 a share for the stock it doesn't already own, the companies said in a joint statement.The statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents